You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
Sensitive Molecular Beacons (MB) Based DNA Microarray
SBC: BIOMACHINES, INC. Topic: CBD02101In the wake of the September 11th attacks and subsequent Anthrax scares, researchers worldwide are working to expand our ability to rapidly assess what poses a terrorism threat to the public. The rapid detection of specific pathogens is required for biod
SBIR Phase II 2004 Department of DefenseOffice for Chemical and Biological Defense -
Point Detector for Biological Material Identification
SBC: Fluid Analytics, Inc Topic: N02118MicroEnergy Technologies (MicroET) in conjunction with ChemImage Inc. (Pittsburg, PA) has a goal to develop an efficient pathogen collector and detector that can be deployed as a point detector with few false alarms. During Phase I we developed a prototy
SBIR Phase II 2004 Department of DefenseOffice for Chemical and Biological Defense -
Microfiber-Based Closures with Hermetic Sealing for Chem Bio Protective Garments
SBC: NANOGRIPTECH Topic: CBD13109Future engagements (especially with near-peer threats) present the possibility of a wide range of anticipated operational situations involving the presence of chemical threat agents. With this, deployment of Military Working Dogs (MWDs) is likely. This creates a situational awareness that MWDs are potentially at risk from exposure to a wide range of hazardous chemicals. Potential threat agents inc ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Dermal Medical Countermeasures for Chemical Weapons Exposure
SBC: Zymeron Corporation Topic: CBD161003The skin is the first line of defense against chemical warfare agents including nerve agents and toxic industrial chemicals, providing a possible barrier or delay to systemic distribution. Some chemicals also can act directly on the skin including the vesicants sulfur mustard and lewisite. Early and rapid skin decontamination is extremely important following exposure to CWAs and TICs because it de ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Hermetic Seals for Chemical/Biological Protective Garments
SBC: CREARE LLC Topic: CBD13109Interfaces on existing military chemical/biological protection garments are not designed to fully eliminate macroscopic and microscopic air gaps at folds, fabric surfaces, or hook-and-loop closures, and thus do not provide a hermetic barrier against exposure. Creare is developing hermetic garment closure systems that seal macroscopic and microscopic gaps at interfaces and closures and provide high ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Medical Countermeasure Development for Viral Induced Encephalitis Using Single DomainAntibodies
SBC: Abzyme Therapeutics, LLC Topic: CBD161004Alphaviruses, infection with which may cause encephalitis and death, are recognized as potential biological warfare agents. There are noapproved medical countermeasures against Alphaviruses. In Phase I, using Abzymes proprietary in vivo Self-Diversifying Camelid SingleDomain Antibody Library (SDALib) platform, broadly reactive single domain camelid VHH antibodies against equine encephalitis viral ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense